Can Alzheimer’s Disease ever be cured? There is hope!

Introduction

As of 2025, approximately 7.2 million Americans aged 65 and older are living with Alzheimer’s disease, representing about 11% of that age group—roughly 1 in 9 individuals. Various authoritative sources indicate that around 10–11% of Americans over 65 are affected by Alzheimer’s.

A 2022 brain health study published in JAMA Neurology reported that 1 in 10 Americans over 65—about 10%—have dementia, and an additional 22% experience mild cognitive impairment (MCI). Alzheimer’s is the most common form of dementia.

I want to share with you some exciting investigations being conducted in the United Kingdom. Studies are underway that involve brain surgery, which is at the cutting edge of dementia research.

In an article recently published by James Gallagher, Health and Science Correspondent, he explained that operations that are focused primarily on brain cancers now also involve a detailed examination of the cortex, which would usually be discarded, while addressing the tumor, which is often deeper in the brain, requiring the outer cortex to be cut.

The cortex is the outer layer of the brain involved in language, memory, and thought. Gallagher, who attended a surgical procedure in Edinburgh, explained, “In most brain surgeries, the removed section of cortex is medical waste and would be binned. But Edinburgh is one of only a handful of centers worldwide where it is collected, with permission, for dementia research.1

The section to be examined is around the size of a thumbnail. Dr Claire Durrant, in her Edinburgh Laboratory, is one of the few working on living adult brain tissue to understand dementia and other diseases.

Dr. Claire Durrant by James Gallagher

The Procedure

It is not necessary to explain here the complex way the brain tissue is examined; suffice it to say that the investigative team exposes the brain slices to toxic proteins called amyloid and tau, which build up in the brains of people with Alzheimer’s disease. This allows them to witness synapse destruction and determine whether it can be prevented. Everything Dr Durrant is seeing so far convinces her that curing Alzheimer’s is not an impossible challenge!

She states, “The evidence we have at the moment is that it is a disease, and that we know from past experiences that disease can be cured. Maybe one day we’ll find evidence that Alzheimer’s disease is inherently part of being human, but at the moment I don’t see that,”

“I’ve not seen so much hope in Alzheimer’s disease research as I do right now. I’m really hopeful we’ll see meaningful change in my lifetime.”

It appears that glimmers of hope came from two drugs – called lecanemab and donanemab – that slow the pace of Alzheimer’s disease. While they were a scientific achievement, their real-world impact on patients has been labelled by some as too small to be noticeable. These were mentioned in the Engage Estero earlier report on available treatments for dementia.

But Prof Tara Spires-Jones, director of the Centre for Discovery Brain Science at the University of Edinburgh, thinks these two drugs have “really opened the door” for cracking Alzheimer’s.

The team is also investigating the role of star-shaped immune cells, called astrocytes, in Alzheimer’s. A new aspect has led to growing recognition that Alzheimer’s may need to be tackled from multiple directions. Lecanemab and donanemab both target the toxic sticky protein called amyloid. Clinical trials of drugs targeting the other protein tau are underway.

The importance of the immune system, inflammation, a person’s blood vessel health, and the interaction between genetics and the environment are advancing understanding of Alzheimer’s.

Prof Spires-Jones thinks there will be three key developments:

  • In the short term, drugs that meaningfully slow or stop the progression of the disease
  • Tools for preventing dementia entirely
  • And, in the long term, a way of curing those who already have symptoms – although she acknowledges that will be much harder.

It is encouraging to note that Prof Spires-Jones believes, “We are five to 10 years away from a treatment that is ‘truly life-changing, ‘ and we will get to the point where we can ‘really make your life normal’ by catching the disease early enough and then halting it.”

But while there is optimism, it will still need research and clinical trials to prove that curing Alzheimer’s is possible. “The human brain is so phenomenally complex that we really just have to see it in people,” Prof Spires-Jones says.

Through our investigative process, Engage Estero will, from time to time, keep you updated on issues we believe are crucial to us.

Conclusions

As we have stated in our earlier articles on Dementia and Alzheimer’s Disease, for many, aging itself can be a source of anxiety. The changes that come with growing older, including changes in memory and cognitive function, can be distressing.

In conclusion, while dementia remains one of the most challenging and heartbreaking conditions of our time, the emerging discoveries in brain science described in this article offer genuine reason for cautious hope. Advances in understanding neural networks, disease mechanisms, and the brain’s capacity for repair are reshaping what was once thought impossible and are moving the field steadily closer to treatments that may slow, halt, or one day even reverse the course of the disease.

For those diagnosed with dementia, and for the families and carers who walk beside them every day, the journey is often marked by grief, exhaustion, and profound love. As research continues to push boundaries, it carries with it the shared hope that future generations may face this disease with better options, greater dignity, and, ultimately, lasting relief. 

References

  1. I’m watching brain surgery to see if Alzheimer’s can ever be cured, James Gallagher, Health and Science Correspondent for the BBC, December 2025. https://www.bbc.com/news/articles/cn4dnwky48wo.
  2. Treating Dementia, Alzheimer’s Disease, and Vascular Dementia: Understanding the Differences. Allan Bowditch, President, Engage Estero. Sept 2025. https://esterotoday.com/treating-dementia-alzheimers-disease-and-vascular-dementia-understanding-the-differences/

Disclaimer: Engage Estero provides this information as a service, and not as treatment or medical advice. Always consult with a physician before starting or changing medical treatment. 

 

Related Articles by Engage Estero

The Value of Music Therapy in a Patient’s Medical Treatment

The Value of Music Therapy in a Patient’s Medical Treatment

The Value of Music Therapy in a Patient’s Medical TreatmentIntroduction The value of music in treating patients—commonly explored through music therapy—is significant and well-documented across various medical and psychological fields. Music therapy serves as a...

Written by

Allan Bowditch

Allan Bowditch

President

Published December 31, 2025 by Engage Estero

  Be Informed,
Get Engaged,
and Make an Impact!

Engage Estero

At Engage Estero, we believe in the power of community. As a nonpartisan, nonpolitical, nonprofit, we conduct evidence-based research to provide unbiased information about local issues, helping you improve your quality of life.